Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹50.27 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹50.27 Cr |
| Fresh Issue | ₹47.60 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹80.00-85.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | RBS |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Choice Capital Advisors Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,600 shares and in multiples thereof
Founded in 2008, Ramdevbaba Solvent Limited produces and distributes physically refined rice bran oil.
The Company is engaged in the manufacture, distribution, marketing and sale of rice bran oil to FMCG companies such as Mother Dairy Fruit & Vegetable Private Limited, Marico Limited and Empire Spices and Foods Ltd. The Company also manufactures, markets and sells rice bran oil under its own brands "Tulsi" and "Sehat" through thirty eight (38) distributors who in turn sell to various retailers in Maharashtra.
The company also manufactures de-oiled rice bran (DORB), which is a by-product of rice bran oil extraction, and sells it as livestock, poultry and fish feed in the states of Maharashtra, Goa, Gujarat, Madhya Pradesh, Andhra Pradesh, Telangana, Karnataka, Kerala and Tamil Nadu. Other by-products such as fatty acid, lecithin, gum, spent soil and wax are sold on the open market.
Ramdevbaba Solvent has two production facilities, one in Mahadula and the other in Bramhapuri near Nagpur in the state of Maharashtra,
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Setting up of new manufacturing facility | 18.81 |
| 2 | Repayment in full or in part, of certain of our outstanding borrowings | 8.42 |
| 3 | Funding the working capital requirements of our Company; and | 12.00 |
| 4 | General corporate purposes | 5.38 |
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 203.41 | 190.63 | 131.35 | 101.25 |
| Total Income | 465.70 | 704.33 | 585.25 | 427.17 |
| Profit After Tax | 8.29 | 13.00 | 6.59 | 6.17 |
| NET Worth | 68.57 | 47.83 | 34.83 | 28.24 |
| Reserves and Surplus | 52.36 | 43.25 | 30.24 | 23.65 |
| Total Borrowing | 99.99 | 99.23 | 64.86 | 44.74 |
| Amount in ₹ Crore | ||||
| KPI | Dec 31, 2023 |
|---|---|
| ROCE | 10.76% |
| Debt / Equity | 1.46% |
| RoNW | 14.24% |
| PAT Margin | 1.79% |
| Price to Book Value | 1.83 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 8.02 | 5.00 |
| P/E (x) | 10.6 | 17.02 |
| Promoter Holding | 81.01% | |
| Market Cap | ₹188.07 Cr. | |
